Market Herald logo

Find out more about this capital raise

Be the first with the news that moves the market
  • PharmaDrug (PHRX) has announced a non-brokered private placement for gross proceeds of $650,000
  • The company issued debenture units comprised of a $1,000 convertible secured debenture and 20,000 common share purchase warrants
  • The company will be issuing 2,089,963 common shares to the holders of its convertible debentures and 200,000 common shares for the satisfaction of an outstanding payable
  • The net proceeds from the offering will be used for working capital purposes
  • PharmaDrug is a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines
  • PharmaDrug Inc. (PHRX) opened trading at C$0.03

PharmaDrug (PHRX) has announced a non-brokered private placement for gross proceeds of $650,000.

The company issued debenture units comprised of a $1,000 convertible secured debenture and 20,000 common share purchase warrants. Each debenture bears interest at a rate of 15 per cent per annum payable monthly, matures one year from the date of issue and is convertible into common shares.  Each warrant entitles the holder to acquire one common share for $0.05 for a period of two years.

The net proceeds from the offering will be used for working capital purposes.

The company will be issuing 2,089,963 common shares to the holders of its convertible debentures and 200,000 common shares for the satisfaction of an outstanding payable. 

The company believes that the payment of the penalty to alleviate cash constraints. The independent members of the board of directors have reviewed and approved the terms of the payment.

PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines including psychedelics, cannabis and naturally-derived approved drugs.

PharmaDrug Inc. (PHRX) opened trading at C$0.03.


More From The Market Herald

" Marvel Biosciences Corp. (TSXV:MRVL) closes non-brokered private placement

Marvel Biosciences Corp. (MRVL)  has closed its previously announced non-brokered private placement for gross proceeds of $720,000.

" First Mining (TSX:FF) announces $5M non-brokered private placement

First Mining Gold (FF) has announced a non-brokered private placement for gross proceeds of approximately $5 million.

" Pasofino Gold (TSXV:VEIN) announces $6.4 million private placement

Pasofino Gold Limited (VEIN) has announced a non-brokered private placement for gross proceeds of up to $6,428,000.
Reliq Health Technologies - CEO Dr. Lisa Crossley

" Reliq Health Technologies (TSXV:RHT) announces eight new contracts

Reliq Health Technologies (RHT) has signed new contracts with six clinics and two physician practices in Idaho, New Mexico, California, Nevada and Texas.